Span PN - Search Results

1

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.

Nagelkerke A, Sieuwerts AM, Bussink J, Sweep FC, Look MP, Foekens JA, Martens JW, Span PN. Nagelkerke A, et al. Among authors: span pn. Endocr Relat Cancer. 2014 Jan 16;21(1):101-12. doi: 10.1530/ERC-13-0183. Print 2014 Feb. Endocr Relat Cancer. 2014. PMID: 24434718

2

EORTC receptor and biomarker study group report analytical and technical evaluation of a thymidine kinase radio-enzymatic assay in breast cancer cytosols.

Span P, Heuvel J, Romain S, Piffanelli A, Martin PM, Geurts-Moespot A, Sweep F. Span P, et al. Anticancer Res. 2000 Mar-Apr;20(2A):681-7. Anticancer Res. 2000. PMID: 10810340

3

Elevated serum endothelin-1 levels in patients with colorectal cancer; relevance for prognosis.

Peeters CF, Thomas CM, Sweep FC, Span PN, Wobbes T, Ruers TM. Peeters CF, et al. Among authors: span pn. Int J Biol Markers. 2000 Oct-Dec;15(4):288-93. doi: 10.1177/172460080001500402. Int J Biol Markers. 2000. PMID: 11192823 Free article.

4

Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.

Span PN, Sweep CG, Manders P, Beex LV, Leppert D, Lindberg RL. Span PN, et al. Cancer. 2003 Jun 1;97(11):2710-5. doi: 10.1002/cncr.11395. Cancer. 2003. PMID: 12767082 Free article.

5

Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome.

Span PN, Bussink J, Manders P, Beex LV, Sweep CG. Span PN, et al. Br J Cancer. 2003 Jul 21;89(2):271-6. doi: 10.1038/sj.bjc.6601122. Br J Cancer. 2003. PMID: 12865916 Free PMC article.

6

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.

Manders P, Beex LV, Tjan-Heijnen VC, Span PN, Sweep CG. Manders P, et al. Among authors: span pn. Cancer. 2003 Nov 15;98(10):2125-32. doi: 10.1002/cncr.11764. Cancer. 2003. PMID: 14601081 Free article.

7

Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients.

Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J, Beex LV. Manders P, et al. Among authors: span pn. Clin Cancer Res. 2003 Dec 15;9(17):6363-70. Clin Cancer Res. 2003. PMID: 14695136

8

Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Foekens JA, Beex LV, Sweep CG. Manders P, et al. Among authors: span pn. Cancer Res. 2004 Jan 15;64(2):659-64. doi: 10.1158/0008-5472.can-03-1820. Cancer Res. 2004. PMID: 14744782

9

Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.

Span PN, Waanders E, Manders P, Heuvel JJ, Foekens JA, Watson MA, Beex LV, Sweep FC. Span PN, et al. J Clin Oncol. 2004 Feb 15;22(4):691-8. doi: 10.1200/JCO.2004.01.072. J Clin Oncol. 2004. PMID: 14966093

10

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.

Manders P, Tjan-Heijnen VC, Span PN, Grebenchtchikov N, Geurts-Moespot AJ, van Tienoven DT, Beex LV, Sweep FC. Manders P, et al. Among authors: span pn. Thromb Haemost. 2004 Mar;91(3):514-21. doi: 10.1160/TH03-07-0467. Thromb Haemost. 2004. PMID: 14983227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters